Company Overview and News

 
Aguia Resources Limited Announces Closing of CAD$5 Million Bought Deal Private Placement Offering

2018-04-12 globenewswire
TORONTO, April 12, 2018 (GLOBE NEWSWIRE) -- Aguia Resources Limited (“Aguia” or the “Company”) (TSX VENTURE:AGRL) (ASX:AGR) announced today that it has concluded a bought deal private placement financing of 14,285,800 units of the Company (the “Units”) at a price of CAD$0.35 per Unit for gross proceeds of approximately CAD$5.0 million (the “Offering”).
Upvote Downvote

 
Aguia Resources Announces Filing of Technical Report

2018-04-11 globenewswire
Aguia Resources Limited (“Aguia” or the “Company”) (TSXV:AGRL) (ASX:AGR) announces that following the release of the results of a Bankable Feasibility Study on March 20, 2018, an updated NI 43-101 Compliant Technical Report for the Três Estradas Phosphate Project has been prepared and filed with the Canadian regulatory authorities.
Upvote Downvote

 
BRIEF-Aguia Resources Limited Announces CAD$5 Mln Bought Deal Private Placement Offering

2018-03-21 reuters
* AGUIA RESOURCES LTD - ENTERED INTO BOUGHT DEAL PRIVATE PLACEMENT FINANCING AGREEMENT TO SELL 14.3 MILLION UNITS AT CAD$0.35 PER UNIT
Upvote Downvote

 
Aguia Resources Limited Announces CAD$5 million Bought Deal Private Placement Offering

2018-03-21 globenewswire
TORONTO, March 21, 2018 (GLOBE NEWSWIRE) -- Aguia Resources Limited (“Aguia” or the “Company”) (TSX VENTURE:AGRL) (ASX:AGR) announced today that it has entered into a bought deal private placement financing agreement to sell 14,285,800 units of the Company (the “Units”) at a price of CAD$0.35 per Unit for gross proceeds of approximately CAD$5.0 million (the “Offering”).
Upvote Downvote

 
Troilus Gold Announces New Senior Management Additions

2018-01-08 marketwired
TORONTO, ONTARIO--(Marketwired - Jan. 8, 2018) - Troilus Gold Corp. (TSX VENTURE:TLG) ("Troilus" or the "Company") is pleased to announce new additions to its technical and capital markets team as it focuses on the mineral expansion and potential restart of the former gold and copper Troilus Mine (the "Troilus Project"). The Troilus Project, located northwest of the Val-d'Or district in Quebec, Canada, produced more than 2,000,000 ounces of gold and nearly 70,000 tonnes of copper from 1997 to 2010.
Upvote Downvote

 
Pitchblack Completes Acquisition of Option to Buy Troilus Gold Project and Announces Corporate Name Change to Troilus Gold Corp.

2017-12-20 marketwired
Pitchblack Resources Ltd. (NEX:PIT.H) ("Pitchblack") is pleased to announce the closing of the previously announced reverse-takeover of Pitchblack resulting in the acquisition of an option to buy the Troilus Gold Project (the "Transaction"), located northeast of the Val-d'Or district in Quebec, Canada.
Upvote Downvote

 
Aguia Ramps Up Exploration of Targets Surrounding Tres Estradas

2017-11-07 marketwired
Brazilian fertiliser developer Aguia Resources Limited (ASX:AGR)(TSX VENTURE:AGRL) ("Aguia" or the "Company") is pleased to update shareholders on its regional exploration activities on properties in close proximity to its flagship Três Estradas project site in Rio Grande do Sul, Brazil.
Upvote Downvote

 
Aguia Resources Limited: Progress Update on the Tres Estradas Bankable Feasibility Study

2017-07-31 marketwired
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.
Upvote Downvote

 
Aguia Resources Limited Announces Buyback of Royalty for Tres Estradas

2017-07-25 marketwired
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.
Upvote Downvote

 
Aguia Resources Limited Announces Final Closing of Private Placement

2017-07-06 marketwired
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.
Upvote Downvote

 
Aguia Resources Limited Announces TSX Venture Exchange Approval and Listing

2017-07-05 marketwired
SYDNEY, AUSTRALIA--(Marketwired - July 5, 2017) - Aguia Resources Limited (the "Company") is pleased to announce that the Company has received confirmation from the TSX Venture Exchange (the "TSXV") that the conditions for listing the Company's ordinary shares for trading on the TSXV (the "Listing") have been satisfied. The TSXV has issued its final Exchange Bulletin on July 5th, 2017 confirming the Listing of the Company's ordinary shares including those ordinary shares of the Company issued and outstanding pursuant to compensation options and other agreements and those issued pursuant to the private placement (the "Private Placement").
Upvote Downvote

 
Aguia Resources bags C$10.8M; gets ready for Canada listing

2017-06-26 proactiveinvestors.com.au
Aguia Resources (ASX:AGR) has successfully completed a substantially oversubscribed C$10.8 million share placement to institutional and sophisticated investors at C$0.40 per share. Furthermore, the company has received conditional approval for its listing application to the TSX Venture Exchange (TSXV).
Upvote Downvote

 
Aguia Resources to lift cash for Brazilian phosphate

2017-06-20 proactiveinvestors.com.au
Aguia Resources (ASX:AGR) has been granted a trading halt by the ASX, pending details of a capital raising.
Upvote Downvote

 
Aguia Resources drills thick intercepts at phosphate project in Brazil

2017-03-23 proactiveinvestors.com.au
Aguia Resources (ASX:AGR) is continuing to receive highly encouraging results from an infill drilling program at its flagship Três Estradas Phosphate Project in southern Brazil.
Upvote Downvote

 
Aguia Resources discovers new target at phosphate project in Brazil

2017-02-16 proactiveinvestors.com.au
Aguia Resources (ASX:AGR) has discovered a new mineralised zone extending from the surface at its flagship Três Estradas Phosphate Project in southern Brazil.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...